News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
501,741 Results
Type
Article (10432)
Company Profile (160)
Press Release (491147)
Multimedia
Podcasts (24)
Webinars (7)
Section
Business (172060)
Career Advice (378)
Deals (26445)
Drug Delivery (18)
Drug Development (54465)
Employer Resources (22)
FDA (9982)
Job Trends (9012)
News (245126)
Policy (18444)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (626)
Accelerated approval (26)
ADA (22)
Adcomms (2)
Allergies (102)
Alliances (34584)
ALS (115)
Alzheimer's disease (1050)
Antibody-drug conjugate (ADC) (323)
Approvals (10611)
Artificial intelligence (392)
ASCO (167)
Autoimmune disease (233)
Automation (34)
Bankruptcy (272)
Belgium (3)
Best Places to Work (7191)
BIO (41)
Biologics (9)
BIOSECURE Act (3)
Biosimilars (135)
BioSpace Insights (30)
Biotechnology (101)
Bispecific (1)
Bladder cancer (143)
Brain cancer (36)
Breast cancer (536)
Cancer (3983)
Cardiovascular disease (245)
Career advice (310)
Career pathing (2)
CAR-T (195)
CDC (3)
CDMO (27)
Celiac Disease (1)
Cell therapy (542)
Cervical cancer (41)
Clinical research (49227)
Collaboration (1434)
Commercialization (3)
Company closure (4)
Compensation (1553)
Complete response letters (35)
COVID-19 (909)
CRISPR (72)
C-suite (900)
Cystic fibrosis (92)
Data (6057)
Denatured (12)
Depression (121)
Dermatology (68)
Diabetes (385)
Diagnostics (4389)
Digital health (42)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (202)
Drug pricing (18)
Drug shortages (3)
Duchenne muscular dystrophy (219)
Earnings (74732)
Editorial (8)
Employer branding (3)
Employer resources (20)
Events (90152)
Executive appointments (773)
FDA (12781)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (1129)
Gene editing (148)
Generative AI (17)
Gene therapy (386)
GLP-1 (371)
Government (1095)
Grass and pollen (2)
Guidances (290)
Healthcare (9710)
Hematology (96)
HIV (57)
Huntington's disease (27)
IgA nephropathy (72)
Immunology and inflammation (156)
Immuno-oncology (76)
Indications (166)
Infectious disease (1122)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (90)
Intellectual property (273)
Interviews (46)
IPO (12635)
IRA (8)
Job creations (2149)
Job search strategy (293)
JPM (10)
Kidney cancer (20)
Labor market (14)
Layoffs (115)
Leadership (6)
Legal (5303)
Licensing (19)
Liver cancer (49)
Longevity (22)
Lung cancer (564)
Lymphoma (270)
Machine learning (34)
Management (7)
Manufacturing (625)
Marketing (8)
MASH (124)
Medical affairs (2)
Medical device (8827)
Medtech (8993)
Mergers & acquisitions (14895)
Metabolic disorders (815)
mRNA (81)
Multiple sclerosis (113)
NASH (5)
Netherlands (1)
Neurodegenerative disease (260)
Neuropsychiatric disorders (57)
Neuroscience (2044)
NextGen: Class of 2026 (3384)
Non-profit (1050)
Now hiring (18)
Obesity (279)
Opinion (42)
Ovarian cancer (166)
Pain (183)
Pancreatic cancer (224)
Parkinson's disease (219)
Partnered (15)
Patents (518)
Patient recruitment (551)
Patient selection (2)
Peanut (33)
People (43226)
Peptides (2)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (16017)
Phase 2 (22056)
Phase 3 (14914)
Pipeline (8041)
Policy (39)
Postmarket research (1584)
Preclinical (6767)
Press Release (34)
Prostate cancer (199)
Psychedelics (19)
Radiopharmaceuticals (212)
Rare diseases (666)
Real estate (3293)
Recruiting (10)
Regenerative medicine (2)
Regulatory (15457)
Reports (27)
Research institute (703)
Resumes & cover letters (53)
Rett syndrome (42)
RNA editing (11)
RSV (52)
Schizophrenia (118)
Series A (205)
Series B (144)
Service/supplier (5)
Sickle cell disease (67)
Special edition (4)
Spinal muscular atrophy (95)
Sponsored (6)
Startups (2316)
Stomach cancer (5)
Supply chain (53)
Tariffs (3)
The Weekly (12)
Vaccines (387)
Venture capital (44)
Weight loss (112)
Women's health (95)
Worklife (1)
Date
Today (51)
Last 7 days (296)
Last 30 days (1470)
Last 365 days (20089)
2026 (14437)
2025 (20209)
2024 (23844)
2023 (27458)
2022 (35744)
2021 (38394)
2020 (34664)
2019 (24299)
2018 (18370)
2017 (19537)
2016 (18705)
2015 (24963)
2014 (22183)
2013 (18709)
2012 (20763)
2011 (20912)
2010 (20749)
Location
Africa (259)
Alabama (81)
Alaska (2)
Arizona (315)
Arkansas (12)
Asia (19311)
Australia (2370)
California (12770)
Canada (3315)
China (625)
Colorado (505)
Connecticut (440)
Delaware (220)
Europe (28121)
Florida (1876)
Georgia (396)
Hawaii (4)
Idaho (47)
Illinois (757)
India (58)
Indiana (337)
Iowa (16)
Japan (438)
Kansas (114)
Kentucky (33)
Louisiana (29)
Maine (26)
Maryland (1264)
Massachusetts (8376)
Michigan (320)
Minnesota (586)
Mississippi (5)
Missouri (85)
Montana (20)
Nebraska (11)
Nevada (124)
New Hampshire (63)
New Jersey (2766)
New Mexico (12)
New York (2950)
North Carolina (1348)
North Dakota (4)
Northern California (6454)
Ohio (315)
Oklahoma (15)
Oregon (20)
Pennsylvania (2330)
Puerto Rico (22)
Rhode Island (33)
South America (432)
South Carolina (78)
South Dakota (1)
Southern California (5262)
Tennessee (131)
Texas (2058)
United States (41182)
Utah (379)
Vermont (1)
Virginia (168)
Washington D.C. (43)
Washington State (1019)
West Virginia (2)
Wisconsin (87)
Wyoming (1)
501,741 Results for "catalyst biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Promatix Biosciences Innovate UK Biomedical Catalyst Grant
July 29, 2026
·
1 min read
Press Releases
Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment
August 25, 2026
·
11 min read
Press Releases
Promatix Biosciences Awarded Innovate UK Biomedical Catalyst Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC
July 28, 2026
·
5 min read
Deals
Angelini inks $4.1B Catalyst buy to enter US rare disease market
Catalyst Pharmaceuticals comes with a trio of approved drugs as Angelini Pharma expands its neuroscience offerings.
May 7, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Catalyst MedTech Helps Imaging Providers See What’s Next in Nuclear Cardiology at ASNC 2026
September 14, 2026
·
4 min read
Press Releases
Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals
July 16, 2026
·
9 min read
Press Releases
Finance & Accounting for Bioscience West debuts in San Diego this December
Discover innovative financial strategies and expert guidance from leading bioscience finance executives at this first-ever West Coast forum.
September 18, 2026
·
1 min read
Psychedelics
All eyes on psychedelic drugmakers as Definium, Compass near major catalysts
Definium Therapeutics’ closely watched anxiety readout could further validate its single-dose LSD candidate, while Compass Pathways advances a psilocybin program through a rolling FDA filing.
August 10, 2026
·
3 min read
·
Gabrielle Masson
Press Releases
Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo
July 29, 2026
·
3 min read
Press Releases
Model Medicines to Present Data on Two First-in-Class Programs Ahead of Catalyst Regulatory Filings at the 2026 BIO International Convention in San Diego
CEO Daniel Haders, PhD, will highlight upcoming catalyst events for the company’s two lead assets: MDL-001, a first-in-class, universal, direct-acting therapeutic for influenza-like-illness (ILI) and chronic hepatitis, targeting the novel RdRp Thumb-1 site, and MDL-4102, a first-in-class therapeutic for various cancers and inflammatory diseases, targeting the epigenetic reader and master regulator of gene transcription, BRD4.
June 24, 2026
·
1 min read
1 of 50,175
Next
